Day: November 5, 2021

Pfizer Giroctocogene Fitelparvovec (Hemophilia A Gene Therapy) AFFINE Phase 3 Study Update

The following is a news release from Pfizer. Read the full statement here (view PDF):We would like to share a recent update to our gene therapy clinical program for Hemophilia A (C3731003; AFFINE study) evaluating giroctocogene fitelparvovec, that we are developing with Sangamo.Following the observation of factor VIII (FVIII) levels greater than 150% in some […]